AP2909A - Pyrazinoisoquinoline Compounds - Google Patents

Pyrazinoisoquinoline Compounds

Info

Publication number
AP2909A
AP2909A AP2011005932A AP2011005932A AP2909A AP 2909 A AP2909 A AP 2909A AP 2011005932 A AP2011005932 A AP 2011005932A AP 2011005932 A AP2011005932 A AP 2011005932A AP 2909 A AP2909 A AP 2909A
Authority
AP
ARIPO
Prior art keywords
pyrazinoisoquinoline
compounds
pyrazinoisoquinoline compounds
Prior art date
Application number
AP2011005932A
Other languages
English (en)
Other versions
AP2011005932A0 (en
Inventor
Julie F Liu
Roger Tung
Scott L Harbeson
Original Assignee
Concert Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Concert Pharmaceuticals Inc filed Critical Concert Pharmaceuticals Inc
Publication of AP2011005932A0 publication Critical patent/AP2011005932A0/xx
Application granted granted Critical
Publication of AP2909A publication Critical patent/AP2909A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AP2011005932A 2009-03-17 2010-03-16 Pyrazinoisoquinoline Compounds AP2909A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21027909P 2009-03-17 2009-03-17
PCT/US2010/027476 WO2010107791A2 (en) 2009-03-17 2010-03-16 Pyrazinoisoquinoline compounds

Publications (2)

Publication Number Publication Date
AP2011005932A0 AP2011005932A0 (en) 2011-10-31
AP2909A true AP2909A (en) 2014-05-31

Family

ID=42670542

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2011005932A AP2909A (en) 2009-03-17 2010-03-16 Pyrazinoisoquinoline Compounds

Country Status (5)

Country Link
US (3) US8563554B2 (de)
EP (1) EP2408771B1 (de)
AP (1) AP2909A (de)
BR (1) BRPI1009199A2 (de)
WO (1) WO2010107791A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
WO2012122028A2 (en) 2011-03-04 2012-09-13 Concert Pharmaceuticals Inc. Pyrazinoisoquinoline compounds
CN102520149A (zh) * 2011-12-26 2012-06-27 江苏省血吸虫病防治研究所 一种体外检测日本血吸虫尾蚴对吡喹酮抗药性的方法
JP7077335B2 (ja) 2016-12-13 2022-05-30 プリンストン ドラッグ ディスカバリー インコーポレイテッド プロテインキナーゼ阻害剤

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1411A (en) * 1839-11-16 Improvement in the machine for turning the heads of wood screws and rivets
US20040198762A1 (en) * 1997-09-05 2004-10-07 Selvaraj Naicker Deuterated rapamycin compounds, method and uses thereof
US20040253180A1 (en) * 1994-03-25 2004-12-16 Foster Robert T. Method of making and using isotope-substituted anti-bacterial agents

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2362539C2 (de) 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2457971A1 (de) 1974-12-07 1976-06-10 Merck Patent Gmbh Verfahren zur herstellung von 2-acyl4-oxo-pyrazino-isochinolin-derivaten
DE2504250A1 (de) 1975-02-01 1976-08-05 Merck Patent Gmbh Tetrahydroisochinolin-derivate und verfahren zu ihrer herstellung
US4303659A (en) 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
JPS57139012A (en) 1981-02-23 1982-08-27 Sankyo Co Ltd Anthelmintic composition
US4447414A (en) 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5994341A (en) 1993-07-19 1999-11-30 Angiogenesis Technologies, Inc. Anti-angiogenic Compositions and methods for the treatment of arthritis
BG61064B1 (bg) 1993-08-12 1996-10-31 Илия Илиев Лекарствено средство за обезпаразитяване на животни
CN1087725C (zh) 1994-03-25 2002-07-17 同位素技术有限公司 用氘代方法增强药物效果
US6221335B1 (en) 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
US6051604A (en) 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
EP0959891A1 (de) 1996-07-30 1999-12-01 Ashmont Holdings Limited Zusammensetzungen gegen helminthen
US6440710B1 (en) 1998-12-10 2002-08-27 The Scripps Research Institute Antibody-catalyzed deuteration, tritiation, dedeuteration or detritiation of carbonyl compounds
GB9925962D0 (en) 1999-11-02 1999-12-29 Novartis Ag Organic compounds
PT1104760E (pt) 1999-12-03 2003-06-30 Pfizer Prod Inc Compostos de sulfamoil-heteroarilpirazole como agentes analgesicos e anti-inflamatorios
US6429211B1 (en) 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
US6689756B2 (en) 2001-03-02 2004-02-10 Integra Lifesciences Corporation Treatment of neurological disease
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
HU229938B1 (en) 2001-05-03 2015-01-28 Hoffmann La Roche Pharmaceutical dosage form of amorphous nelfinavir mesylate
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AU2003249244A1 (en) 2002-07-15 2004-02-02 Combinatorx, Incorporated Methods for the treatment of neoplasms
TW200413273A (en) 2002-11-15 2004-08-01 Wako Pure Chem Ind Ltd Heavy hydrogenation method of heterocyclic rings
AU2003260818A1 (en) 2002-11-28 2004-06-18 Moore, Bronwyn Treatment of immune system dysfunction
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
EP1809247A1 (de) 2004-09-29 2007-07-25 Cordis Corporation Pharmazeutische dosierformen von stabilen amorphen rapamycin-artigen verbindungen
WO2006061214A1 (en) 2004-12-10 2006-06-15 Bayer Healthcare Ag Anthelmintic composition
CN100503582C (zh) 2005-03-01 2009-06-24 江苏工业学院 吡喹酮合成工艺
WO2006120495A1 (fr) 2005-05-13 2006-11-16 Advanced Scientific Developements Composition pharmaceutique comprenant un antiviral, an antitumoral ou un antiparasitaire, et un actif choisi parmi le carveol, le thymol, l’eugenol, le borneol et le carvacrol
US20090264479A1 (en) 2005-07-26 2009-10-22 Cameron Black Papain Family Cysteine Protease Inhibitors for the Treatment of Parasitic Diseases
CA2624179A1 (en) 2005-10-06 2007-04-12 Auspex Pharmaceuticals, Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
US7750168B2 (en) 2006-02-10 2010-07-06 Sigma-Aldrich Co. Stabilized deuteroborane-tetrahydrofuran complex
JO2630B1 (en) 2006-04-13 2012-06-17 نوفارتيس ايه جي Organic compounds
MX2009002398A (es) 2006-09-05 2009-03-16 Schering Corp Combinaciones farmaceuticas para manejo de lipidos y en el tratamiento de aterosclerosis y estatosis hepatica.
US8563554B2 (en) 2009-03-17 2013-10-22 Concert Pharmaceuticals, Inc. Deuterated pyrazinoisoquinoline compounds
WO2012122028A2 (en) 2011-03-04 2012-09-13 Concert Pharmaceuticals Inc. Pyrazinoisoquinoline compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1411A (en) * 1839-11-16 Improvement in the machine for turning the heads of wood screws and rivets
US20040253180A1 (en) * 1994-03-25 2004-12-16 Foster Robert T. Method of making and using isotope-substituted anti-bacterial agents
US20040198762A1 (en) * 1997-09-05 2004-10-07 Selvaraj Naicker Deuterated rapamycin compounds, method and uses thereof

Also Published As

Publication number Publication date
EP2408771B1 (de) 2016-11-16
BRPI1009199A2 (pt) 2016-03-08
US20160060263A1 (en) 2016-03-03
WO2010107791A3 (en) 2010-11-18
WO2010107791A4 (en) 2011-01-13
US20140107127A1 (en) 2014-04-17
US8563554B2 (en) 2013-10-22
WO2010107791A2 (en) 2010-09-23
EP2408771A2 (de) 2012-01-25
US9199986B2 (en) 2015-12-01
US20120149709A1 (en) 2012-06-14
AP2011005932A0 (en) 2011-10-31

Similar Documents

Publication Publication Date Title
GB0907425D0 (en) Compounds
GB0918249D0 (en) Compounds
GB0907515D0 (en) Compounds
EP2491025A4 (de) Azaazulenverbindungen
GB0914856D0 (en) Compounds
GB0919194D0 (en) Compounds
GB0922302D0 (en) Compounds
GB0905641D0 (en) Compounds
GB0919594D0 (en) Compounds
AP2909A (en) Pyrazinoisoquinoline Compounds
GB0915519D0 (en) Ntithrombotic compounds
GB0911000D0 (en) Compounds
GB0909672D0 (en) Compounds
EP2443115A4 (de) Verbindungen
GB0908942D0 (en) Compounds
GB0902156D0 (en) Compounds
GB0900456D0 (en) Compounds
GB0906854D0 (en) Compounds
GB0905054D0 (en) Compounds
GB0902259D0 (en) Compounds
GB0904746D0 (en) Compounds
GB0904729D0 (en) Compounds
GB0902391D0 (en) Compounds
GB0903492D0 (en) Compounds
GB0902796D0 (en) Compounds